{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T22:55:55Z","timestamp":1767135355935,"version":"build-2238731810"},"update-to":[{"DOI":"10.1002\/14651858.cd003614.pub2","type":"retraction","label":"Retraction","source":"retraction-watch","updated":{"date-parts":[[2017,3,20]],"date-time":"2017-03-20T00:00:00Z","timestamp":1489968000000},"record-id":"31029"},{"DOI":"10.1002\/14651858.cd003614","type":"retraction","label":"Retraction","source":"retraction-watch","updated":{"date-parts":[[2017,3,20]],"date-time":"2017-03-20T00:00:00Z","timestamp":1489968000000},"record-id":"31030"},{"DOI":"10.1002\/14651858.cd003614.pub2","type":"withdrawal","label":"Withdrawal","source":"publisher","updated":{"date-parts":[[2017,3,20]],"date-time":"2017-03-20T00:00:00Z","timestamp":1489968000000}}],"reference-count":130,"publisher":"Wiley","issue":"3","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd003614.pub3","type":"journal-article","created":{"date-parts":[[2017,3,20]],"date-time":"2017-03-20T11:20:39Z","timestamp":1490008839000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Trimetazidine for stable angina"],"prefix":"10.1002","volume":"2017","author":[{"given":"Agust\u00edn","family":"Ciapponi","sequence":"first","affiliation":[{"name":"Institute for Clinical Effectiveness and Health Policy (IECS-CONICET); Argentine Cochrane Centre; Dr. Emilio Ravignani 2024 Buenos Aires Capital Federal Argentina C1414CPV"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rudolf","family":"Pizarro","sequence":"additional","affiliation":[{"name":"Hospital Italiano de Buenos Aires; Cardiac Services; Gasc\u00f3n 450 Buenos Aires Argentina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeff","family":"Harrison","sequence":"additional","affiliation":[{"name":"Faculty of Medical and Health Sciences; School of Pharmacy; Buidling 504 85 Park Road Grafton Auckland New Zealand"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2017,3,20]]},"reference":[{"issue":"5","key":"10.1002\/14651858.CD003614.pub3-BIB1|cit1","first-page":"261","article-title":"Clinical efficacy of trimetazidine in stable angina pectoris: A double-blind placebo controlled study","volume":"24","author":"Aksoyek","year":"1996","journal-title":"Turk Kardiyoloji Dernegi Arsivi"},{"issue":"1","key":"10.1002\/14651858.CD003614.pub3-BIB2|cit2","first-page":"39","article-title":"First american study of trimetazidine (FAST)","volume":"14","author":"Berm\u00fadez Arias","year":"1995","journal-title":"Archivos Venezolanos de Farmacolog\u00eda y Terap\u00e9utica"},{"issue":"1","key":"10.1002\/14651858.CD003614.pub3-BIB3|cit3","first-page":"39","article-title":"First american study of trimetazidine (FAST)","volume":"14","author":"Berm\u00fadez Arias","year":"1995","journal-title":"Archivos Venezolanos de Farmacolog\u00eda y Terap\u00e9utica"},{"key":"10.1002\/14651858.CD003614.pub3-BIB4|cit4","first-page":"49","article-title":"Value of combination of Trimetazidine with a calcium inhibitor in the treatment of chronic coronary insufficiency. Double-blind controlled study versus placebo","volume":"35","author":"Brochier","year":"1986","journal-title":"Annales de Cardiologie et d'Angeiologie"},{"issue":"Symp","key":"10.1002\/14651858.CD003614.pub3-BIB5|cit5","first-page":"80","article-title":"Trimetazidine in current cardiologic practice","volume":"91","author":"Deroux","year":"1984","journal-title":"Gazette Medicale"},{"key":"10.1002\/14651858.CD003614.pub3-BIB6|cit6","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1007\/BF00051287","article-title":"Combination of trimetazidine with nifedipine in effort angina","volume":"4","author":"Monpere","year":"1990","journal-title":"Cardiovascular Drugs & Therapy"},{"issue":"9","key":"10.1002\/14651858.CD003614.pub3-BIB7|cit7","first-page":"395","article-title":"Trimetazidine in the treatment of angina pectoris","volume":"22","author":"Brodbin","year":"1968","journal-title":"British Journal of Clinical Practice"},{"issue":"Suppl 4","key":"10.1002\/14651858.CD003614.pub3-BIB8|cit8","first-page":"115","article-title":"Cardioprotective effect of trimetazidine in severe ischemic cardiomyopathy","volume":"4","author":"Bricaud","year":"1990","journal-title":"Cardiovascular Drugs & Therapy"},{"key":"10.1002\/14651858.CD003614.pub3-BIB9|cit9","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1093\/oxfordjournals.eurheartj.a059685","article-title":"Therapeutic value of cardioprotective agent in patients with severe ischemic cardiomyopathy","volume":"11","author":"BrottierL","year":"1990","journal-title":"European Heart Journal"},{"issue":"9","key":"10.1002\/14651858.CD003614.pub3-BIB10|cit10","first-page":"36","article-title":"Decrease in the sensitivity to the anti-ischemic effect of propranolol and prospects for correcting it in patients with stable angina pectoris","volume":"74","author":"Butina","year":"2002","journal-title":"Terapevticheskii Arkhiv"},{"issue":"26 Suppl","key":"10.1002\/14651858.CD003614.pub3-BIB11|cit11","first-page":"93","article-title":"Value of addition of trimetazidine to calcium antagonist treatment in chronic coronary insufficiency","volume":"91","author":"Chutz","year":"1984","journal-title":"Gazette Medicale"},{"issue":"Suppl 4","key":"10.1002\/14651858.CD003614.pub3-BIB12|cit12","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1007\/BF00051292","article-title":"Comparison of trimetazidine with nifedipine in effort angina: a double blind, crossover study","volume":"4","author":"Dalla-Volta","year":"1990","journal-title":"Cardiovascular Drugs & Therapy"},{"issue":"3","key":"10.1002\/14651858.CD003614.pub3-BIB13|cit13","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/j.1365-2125.1994.tb04276.x","article-title":"Trimetazidine: a new concept in the treatment of angina. Comparison with propranolol in patients with stable angina. Trimetazidine European Multicenter Study Group","volume":"37","author":"Detry JM. Sellier P. Pennaforte S. Cokkinos D. Dargie H. Mathes","year":"1994","journal-title":"British Journal of Clinical Pharmacology"},{"key":"10.1002\/14651858.CD003614.pub3-BIB14|cit14","first-page":"31","article-title":"Controlled trial of the antianginal activity of trimetazidine: double blind cross-over trial versus reference drug (prenylamine)","volume":"3","author":"Grosgogeat","year":"1987","journal-title":"Int J Clin Pract (Hong-Kong)"},{"issue":"5","key":"10.1002\/14651858.CD003614.pub3-BIB15|cit15","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/S0003-3928(02)00129-4","article-title":"Coronary artery disease observed in general hospitals: ETTIC study.Comparison between trimetazidine and mononitrate isosorbide for patients receiving betablockers","volume":"51","author":"Hanania","year":"2002","journal-title":"Annales de Cardiologie et d Angeiologie"},{"issue":"3","key":"10.1002\/14651858.CD003614.pub3-BIB16|cit16","first-page":"162","article-title":"Trimetazidine and stable angina a double-blind trial","volume":"73","author":"Kunjara Na Ayudhya","year":"1990","journal-title":"Journal of the Medical Association of Thailand"},{"key":"10.1002\/14651858.CD003614.pub3-BIB17|cit17","doi-asserted-by":"crossref","first-page":"12B","DOI":"10.1016\/S0002-9149(99)80456-1","article-title":"Combination therapy of trimetazidine with diltiazem in patients with coronary artery disease","volume":"76","author":"Levy","year":"1995","journal-title":"American Journal of Cardiology"},{"issue":"7","key":"10.1002\/14651858.CD003614.pub3-BIB18|cit18","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/S0002-9149(98)00500-1","article-title":"Effects of Trimetazidine on ischemic left ventricular dysfunction in patients with coronary artery disease","volume":"82","author":"Lu","year":"1988","journal-title":"American Journal of Cardiology"},{"issue":"4","key":"10.1002\/14651858.CD003614.pub3-BIB19|cit19","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1136\/hrt.78.4.353","article-title":"Combination treatment with trimetazidine and diltiazem in angina pectoris","volume":"78","author":"Manchanda","year":"1997","journal-title":"Heart"},{"key":"10.1002\/14651858.CD003614.pub3-BIB20|cit20","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0167-5273(02)00367-4","article-title":"Treatment of stable angina with low dose diltiazem in combination with the metabolic agent trimetazidine","volume":"88","author":"Manchanda","year":"2003","journal-title":"International Journal of Cardiology"},{"issue":"11","key":"10.1002\/14651858.CD003614.pub3-BIB21|cit21","first-page":"553","article-title":"Trimetazidine in the treatment of angina pectoris","volume":"21","author":"Mehrotra","year":"1967","journal-title":"British Journal of Clinical Practice"},{"key":"10.1002\/14651858.CD003614.pub3-BIB22|cit22","doi-asserted-by":"crossref","first-page":"8","DOI":"10.2165\/00044011-199713010-00002","article-title":"Antianginal efficacy of die combination treatment of Trimetazidine-propanolol compared with isosorbide dinitrate-propanolol in patients with stable angina","volume":"13","author":"Michaelidis","year":"1997","journal-title":"Clin Drug Invest"},{"issue":"35","key":"10.1002\/14651858.CD003614.pub3-BIB23|cit23","first-page":"1775","article-title":"Effectiveness of trimetazidine in stable effort angina due to chronic coronary insufficiency. A double-blind versus placebo study","volume":"15","author":"Passeron","year":"1986","journal-title":"Presse Medicale"},{"key":"10.1002\/14651858.CD003614.pub3-BIB24|cit24","first-page":"3503","article-title":"Controlled trial versus placebo of trimetazidine (Vastarel 20 mg) in stable angina","volume":"109(SUPPL. 36)","author":"Sellier","year":"1987","journal-title":"Concours Medical"},{"issue":"3","key":"10.1002\/14651858.CD003614.pub3-BIB25|cit25","first-page":"55","article-title":"The efficacy of trimetazidine in stable effort angina. double-blind, placebo controlled study","volume":"83","author":"Prasad","year":"1989","journal-title":"Ind Med J"},{"issue":"35","key":"10.1002\/14651858.CD003614.pub3-BIB26|cit26","first-page":"1779","article-title":"Clinical effectiveness of trimetazidine in stable effort angina. A double-blind versus placebo controlled study","volume":"15","author":"Gallet","year":"1986","journal-title":"Presse Medicale"},{"issue":"Suppl 4","key":"10.1002\/14651858.CD003614.pub3-BIB27|cit27","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1007\/BF00051286","article-title":"Chronic effects of trimetazidine on ergometric parameters in effort angina","volume":"4","author":"Sellier","year":"1990","journal-title":"Cardiovascular Drugs & Therapy"},{"issue":"9","key":"10.1002\/14651858.CD003614.pub3-BIB28|cit28","first-page":"1331","article-title":"Effects of trimetazidine on ergometric parameters in angina of effort: A controlled multicentre double-blind versus placebo trial","volume":"79","author":"Sellier","year":"1986","journal-title":"Archives des Maladies du Coeur et des Vaisseaux"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD003614.pub3-BIB29|cit29","first-page":"S25","article-title":"Anti-ischaemic efficacy and tolerability of trimetazidine administered to patients with angina pectoris: results of three studies","volume":"12","author":"Szwed","year":"2001","journal-title":"Coron Artery Dis"},{"issue":"11","key":"10.1002\/14651858.CD003614.pub3-BIB30|cit30","first-page":"58","article-title":"Comparative efficacy of combined therapy with preductal and amino acid composition in elderly patients with coronary heart disease and class II-III angina","volume":"71","author":"Zaslavskaia","year":"1999","journal-title":"Terapevticheskii Arkhiv"},{"key":"10.1002\/14651858.CD003614.pub3-BIB31|cit31","first-page":"80","article-title":"Trimetazidine in current cardiologic practice","volume":"91(Symp)","author":"Deroux","year":"1984","journal-title":"Gazette Medicale"},{"key":"10.1002\/14651858.CD003614.pub3-BIB32|cit32","first-page":"96","article-title":"Therapeutic value of addition of trimetazidine to beta blocker treatment in chronic coronary insufficiency","volume":"91(Symp)","author":"Fauvel","year":"1984","journal-title":"Gazette Medicale"},{"issue":"12","key":"10.1002\/14651858.CD003614.pub3-BIB33|cit33","first-page":"1065","article-title":"Comparison of trimetazidine with atenolol in patients with syndrome X: effects on diastolic function and exercise tolerance","volume":"44","author":"Leonardo","year":"1999","journal-title":"Cardiologia"},{"key":"10.1002\/14651858.CD003614.pub3-BIB34|cit34","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/BF01616842","article-title":"The effect of trimetazidine in the Treatment of Microvascular Angina","volume":"8","author":"Nalbantgil","year":"1999","journal-title":"International Journal of Angiology"},{"issue":"2","key":"10.1002\/14651858.CD003614.pub3-BIB35|cit35","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/00019501-200003000-00012","article-title":"Effects of trimetazidine on clinical symptoms and tolerance of exercise of patients with syndrome X: a preliminary study","volume":"11","author":"Rogacka","year":"2000","journal-title":"Coronary Artery Disease"},{"key":"10.1002\/14651858.CD003614.pub3-BIB36|cit36","first-page":"1771","article-title":"Ergometric effects of a single administration of trimetazidine","volume":"15","author":"Sellier","year":"1986","journal-title":"Presse Medicale"},{"key":"10.1002\/14651858.CD003614.pub3-BIB37|cit37","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/BF00544569","article-title":"Acute effects of trimetazidine evaluated by exercise testing","volume":"33","author":"Sellier","year":"1987","journal-title":"European Journal of Clinical Pharmacology"},{"key":"10.1002\/14651858.CD003614.pub3-BIB38|cit38","first-page":"237","article-title":"Efficacy and tolerance of trimetazidine in combination with a conventional antianginal drug in patients with stable effort angina","volume":"4","author":"Szwed","year":"1997","journal-title":"Diagn Treat Cardiol"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD003614.pub3-BIB39|cit39","first-page":"S25","article-title":"Anti-ischaemic efficacy and tolerability of trimetazidine administered to patients with angina pectoris: results of three studies","volume":"12","author":"Szwed","year":"2001","journal-title":"Coronary Artery Disease"},{"issue":"21","key":"10.1002\/14651858.CD003614.pub3-BIB40|cit40","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.1161\/01.CIR.99.21.2829","article-title":"ACC\/AHA\/ACP-ASIM Guidelines for the Management of Patients With Chronic Stable Angina: Executive Summary and Recommendations: A Report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients With Chronic Stable Angina)","volume":"99","author":"Gibbons","year":"1999","journal-title":"Circulation"},{"key":"10.1002\/14651858.CD003614.pub3-BIB41|cit41","unstructured":"Gibbons RJ Abrams J Chatterjee K Daley J Deedwania PC Douglas JS ACC\/AHA 2002 guideline update for the management of patients with chronic stable angina: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for the Management of Patients with Chronic Stable Angina) Available at www.acc.org\/clinical\/guidelines\/stable\/stable.pdf. [Accessed 1\/7\/2005] 2002"},{"key":"10.1002\/14651858.CD003614.pub3-BIB42|cit42","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/0140-6736(91)91900-F","article-title":"Efficacy of nifedipine and isosorbide mononitrate in combination with atenolol in stable angina","volume":"338","author":"Akhras","year":"1991","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD003614.pub3-BIB43|cit43","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1161\/01.CIR.82.5.1629","article-title":"Ten year follow up of survival and myocardial infarction in the randomised coronary artery surgery study","volume":"82","author":"Alderman","year":"1990","journal-title":"Circulation"},{"key":"10.1002\/14651858.CD003614.pub3-BIB44|cit44","unstructured":"Alderson P Green S [Editors] Cochrane Collaboration open learning material for reviewers. Version 1.1 http:\/\/www.cochrane-net.org\/openlearning\/ [Accessed 1\/7\/2005] 2002"},{"key":"10.1002\/14651858.CD003614.pub3-BIB45|cit45","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2165\/00002018-199819010-00003","article-title":"Choosing the most appropriate treatment for stable angina safety: safety considerations","volume":"19","author":"Asirvatham","year":"1998","journal-title":"Drug Safety"},{"key":"10.1002\/14651858.CD003614.pub3-BIB46|cit46","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/bdd.350","article-title":"Pharmacokinetic profile of a modified release formulation of trimetazidine (TMZ MR 35 mg) in the elderly and patients with renal failure","volume":"24","author":"Barr\u00e9","year":"2003","journal-title":"Biopharmaceutics & Drug Disposition"},{"key":"10.1002\/14651858.CD003614.pub3-BIB47|cit47","first-page":"I","article-title":"Trimetazidine improves the contractile response of hibernating myocardium to low-dose dobutamine in ischemic cardiomyopathy","volume":"Suppl","author":"Belardinelli","year":"1998","journal-title":"Circulation"},{"issue":"23","key":"10.1002\/14651858.CD003614.pub3-BIB48|cit48","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1053\/euhj.2001.2653","article-title":"Effects of trimetazidine on the contractile response of chronically dysfunctional myocardium to low-dose dobutamine in ischaemic cardiomyopathy","volume":"22","author":"Belardinelli","year":"2001","journal-title":"European Heart Journal"},{"key":"10.1002\/14651858.CD003614.pub3-BIB49|cit49","first-page":"267","article-title":"Angioplasty and bypass surgery","volume-title":"Clinical trials in cardiovascular disease","author":"Bell","year":"1999"},{"key":"10.1002\/14651858.CD003614.pub3-BIB50|cit50","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1080\/01621459.1989.10478782","article-title":"An assessment of publication bias using a sample of published clinical trials","volume":"84","author":"Berlin","year":"1989","journal-title":"Journal of the American Statistical Association"},{"key":"10.1002\/14651858.CD003614.pub3-BIB51|cit51","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1177\/000331979704800505","article-title":"Effects of trimetazidine on heart rate variability and left ventricular systolic perfomance in patients with coronary artery disease after percutaneous transluminal angioplasty","volume":"48","author":"Birand","year":"1997","journal-title":"Angiology"},{"key":"10.1002\/14651858.CD003614.pub3-BIB52|cit52","volume-title":"Heart Disease: a textbook of cardiovascular medicine","author":"Braunwald","year":"1992"},{"key":"10.1002\/14651858.CD003614.pub3-BIB53|cit53","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1093\/oxfordjournals.eurheartj.a059685","article-title":"Therapeutic value of a cardioprotective agent in patients with severe ischaemic cardiomyopathy","volume":"11","author":"Brottier","year":"1990","journal-title":"European Heart Journal"},{"issue":"7253","key":"10.1002\/14651858.CD003614.pub3-BIB54|cit54","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1136\/bmj.321.7253.73","article-title":"Percutaneous transluminal coronary angioplasty versus medical treatment for non-acute coronary heart disease: meta-analysis of randomised controlled trials","volume":"321","author":"Bucher","year":"2000","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD003614.pub3-BIB55|cit55","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1037\/h0040950","article-title":"Factors relevant to the validity of experiments in social settings","volume":"54","author":"Campbell","year":"1957","journal-title":"Psychological Bulletin"},{"issue":"3","key":"10.1002\/14651858.CD003614.pub3-BIB56|cit56","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1001\/jama.291.3.309","article-title":"Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial","volume":"291","author":"Chaitman","year":"2004","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD003614.pub3-BIB57|cit57","unstructured":"Clarke M Oxman AD Cochrane Reviewers' Handbook 4.2.0 [updated March 2003]; Section 8.6.2 In: The Cochrane Library, Issue 2, 2003. Oxford: Update Software"},{"issue":"Suppl A","key":"10.1002\/14651858.CD003614.pub3-BIB58|cit58","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1093\/eurheartj\/17.suppl_A.29","article-title":"Can improved quality of care reduce the costs of managing angina pectoris?","volume":"17","author":"Cleland","year":"1996","journal-title":"European Heart Journal"},{"issue":"Suppl B","key":"10.1002\/14651858.CD003614.pub3-BIB59|cit59","doi-asserted-by":"crossref","first-page":"B27","DOI":"10.1093\/eurheartj\/18.suppl_B.27","article-title":"Pharmacological treatment of ischaemic heart disease. Monotherapy vs combination therapy","volume":"18","author":"Cohn","year":"1997","journal-title":"European Heart Journal"},{"key":"10.1002\/14651858.CD003614.pub3-BIB60|cit60","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0895-4356(94)00172-M","article-title":"Methodologic guidelines for systematic reviews of randomized control trials in health care from the Potsdam consultation on meta-analysis","volume":"48","author":"Cook","year":"1995","journal-title":"Journal of Clinical Epidemiology"},{"issue":"5","key":"10.1002\/14651858.CD003614.pub3-BIB61|cit61","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1517\/14656566.2.5.857","article-title":"Trimetazidine for stable angina pectoris","volume":"2","author":"Cross","year":"2001","journal-title":"Expert Opinion on Pharmacotherapy"},{"issue":"5","key":"10.1002\/14651858.CD003614.pub3-BIB62|cit62","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1136\/hrt.81.5.546","article-title":"Investigation and management of stable angina: revised guidelines 1998","volume":"81","author":"de","year":"1999","journal-title":"Heart"},{"key":"10.1002\/14651858.CD003614.pub3-BIB63|cit63","first-page":"11","article-title":"Are you sure that's a standard deviation?","volume":"Issue 10","author":"Deeks","year":"1997","journal-title":"Cochrane news"},{"issue":"5A","key":"10.1002\/14651858.CD003614.pub3-BIB64|cit64","doi-asserted-by":"crossref","first-page":"50K","DOI":"10.1016\/S0002-9149(98)00537-2","article-title":"Metabolic management of ischemic heart disease: Clinical data with trimetazidine","volume":"82","author":"Desideri","year":"1998","journal-title":"American Journal of Cardiology"},{"issue":"6","key":"10.1002\/14651858.CD003614.pub3-BIB65|cit65","doi-asserted-by":"crossref","first-page":"8B","DOI":"10.1016\/S0002-9149(99)80455-X","article-title":"Trimetazidine European Multicenter Study versus propranolol in stable angina pectoris: Contribution of holter electrocardiographic ambulatory monitoring","volume":"76","author":"Detry","year":"1995","journal-title":"American Journal of Cardiology"},{"key":"10.1002\/14651858.CD003614.pub3-BIB66|cit66","first-page":"441","article-title":"Treatment of Angina by Vastarel 20 mg in everyday medical practice","volume":"9","author":"Drobinsky","year":"1985","journal-title":"La Vie M\u00e9dicale"},{"key":"10.1002\/14651858.CD003614.pub3-BIB67|cit67","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD003614.pub3-BIB68|cit68","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/S0140-6736(97)02419-7","article-title":"Language bias in randomised controlled trials published in English and German","volume":"350","author":"Egger","year":"1997","journal-title":"Lancet"},{"issue":"5","key":"10.1002\/14651858.CD003614.pub3-BIB69|cit69","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s11886-000-0057-7","article-title":"Implications of the atorvastatin versus revascularization treatment (AVERT) study for the clinician","volume":"2","author":"Eisenberg","year":"2000","journal-title":"Current Cardiology Reports"},{"issue":"1","key":"10.1002\/14651858.CD003614.pub3-BIB70|cit70","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/ije\/31.1.140","article-title":"Meta-analyses involving cross-over trials: methodological issues","volume":"31","author":"Elbourne","year":"2002","journal-title":"International Journal of Epidemiology"},{"key":"10.1002\/14651858.CD003614.pub3-BIB71|cit71","article-title":"Drugex drug evaluations: Trimetazidine","volume-title":"<http:\/\/micromedex.med.umich.edu\/mdxcgi\/display.exe?CTL=E:\\mdx\\mdxcgi\\MEGAT.SYS&SET=1C58B3973C5F7200&SYS=1&T=2099> [accessed 1\/7\/2005]","author":"Elenbaas","year":"2004"},{"issue":"18","key":"10.1002\/14651858.CD003614.pub3-BIB72|cit72","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1053\/euhj.1999.2439","article-title":"Effect of 48-h intravenous trimetazidine on short- and long-term outcomes of patients with acute myocardial infarction, with and without thrombolytic therapy; A double-blind, placebo-controlled, randomized trial","volume":"21","year":"2000","journal-title":"European Heart Journal"},{"issue":"3","key":"10.1002\/14651858.CD003614.pub3-BIB73|cit73","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1093\/oxfordjournals.eurheartj.a015259","article-title":"Management of stable angina pectoris. Recommendations of the Task Force of the European Society of Cardiology","volume":"18","author":"Julian","year":"1997","journal-title":"European Heart Journal"},{"key":"10.1002\/14651858.CD003614.pub3-BIB74|cit74","first-page":"486","article-title":"Cardioprotective effect of trimetazidine during coronary artery graft surgry","volume":"33","author":"Fabiani","year":"1992","journal-title":"Journal of Cardiovascular Surgery"},{"key":"10.1002\/14651858.CD003614.pub3-BIB75|cit75","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/j.1742-1241.2000.tb11923.x","article-title":"Bisoprolol alone and in combination with amlodipine or nifedipine in the treatment of chronic stable angina","volume":"54","author":"Ferguson","year":"2000","journal-title":"International Journal of Clinical Practice"},{"key":"10.1002\/14651858.CD003614.pub3-BIB76|cit76","first-page":"12","article-title":"Introduction","volume-title":"Clinical epidemiology - the essentials","author":"Fletcher","year":"1988"},{"issue":"1","key":"10.1002\/14651858.CD003614.pub3-BIB77|cit77","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1093\/oxfordjournals.eurheartj.a014699","article-title":"The Total Ischaemic Burden European Trial (TIBET). Effects of atenolol, nifedipine SR and their combination on the exercise test and the total ischaemic burden in 608 patients with stable angina","volume":"17","author":"Fox","year":"1996","journal-title":"European Heart Journal"},{"issue":"Suppl A","key":"10.1002\/14651858.CD003614.pub3-BIB78|cit78","doi-asserted-by":"crossref","first-page":"A113","DOI":"10.1093\/eurheartj\/18.suppl_A.113","article-title":"How European cardiologists perceive the role of calcium antagonists in the treatment of stable angina","volume":"18","author":"Fox","year":"1997","journal-title":"European Heart Journal"},{"issue":"5","key":"10.1002\/14651858.CD003614.pub3-BIB79|cit79","doi-asserted-by":"crossref","first-page":"E18","DOI":"10.1016\/S0002-8703(03)00415-0","article-title":"Short- and long-term beneficial effects of trimetazidine in patients with diabetes and ischemic cardiomyopathy","volume":"146","author":"Fragasso","year":"2003","journal-title":"American Heart Journal"},{"key":"10.1002\/14651858.CD003614.pub3-BIB80|cit80","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/BF00877927","article-title":"Mechanisms of nitrate tolerance","volume":"8","author":"Fung","year":"1994","journal-title":"Cardiovascular Drugs & Therapy"},{"issue":"6","key":"10.1002\/14651858.CD003614.pub3-BIB81|cit81","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/0735-1097(94)90367-0","article-title":"Trends in acute myocardial infarction and coronary artery disease death in the United States","volume":"23","author":"Gillum","year":"1994","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1002\/14651858.CD003614.pub3-BIB82|cit82","series-title":"9th International Cochrane Colloquium Abstracts, Lyon, France, 9-13 October 2001 Abstract no 1:pa003","article-title":"Meta-analysis of continuous data: does the end justify the mean?","author":"Green","year":"2001"},{"key":"10.1002\/14651858.CD003614.pub3-BIB83|cit83","first-page":"74","article-title":"Vastarel 20 MG: Efficacy and safety of use in cardiology","volume":"110","author":"Guillaumet","year":"1982","journal-title":"Tempo Med"},{"issue":"1","key":"10.1002\/14651858.CD003614.pub3-BIB84|cit84","first-page":"99-106, 111-3","article-title":"Management of stable coronary artery disease","volume":"56","author":"Gutstein","year":"1997","journal-title":"American Family Physician"},{"key":"10.1002\/14651858.CD003614.pub3-BIB85|cit85","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/j.1527-3466.1988.tb00381.x","article-title":"Trimetazidine, a cellular anti-ischaemic agent","volume":"6","author":"Harpey","year":"1989","journal-title":"Cardiovascular Drugs Review"},{"key":"10.1002\/14651858.CD003614.pub3-BIB86|cit86","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1001\/archinte.155.7.670","article-title":"Is cholesterol lowering an alternative to revascularization in some patients with coronary artery disease?","volume":"155","author":"Havranek","year":"1995","journal-title":"Archives of Internal Medicine"},{"issue":"20","key":"10.1002\/14651858.CD003614.pub3-BIB87|cit87","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1001\/jama.281.20.1927","article-title":"Meta-analysis of trials comparing beta-blockers, calcium antagonists, and nitrates for stable angina","volume":"281","author":"Heidenreich","year":"1999","journal-title":"JAMA"},{"issue":"1","key":"10.1002\/14651858.CD003614.pub3-BIB88|cit88","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0733-8651(18)30315-1","article-title":"The prognosis in stable and unstable angina","volume":"9","author":"Hilton","year":"1991","journal-title":"ardiology Clinics"},{"issue":"4","key":"10.1002\/14651858.CD003614.pub3-BIB89|cit89","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/j.1742-1241.2001.tb11029.x","article-title":"Combination therapy in angina: A review of combined haemodynamic and treatment and the role for combined haemodynamic and cardiac metabolic agents","volume":"55","author":"Jackson","year":"2001","journal-title":"International Journal of Clinical Practice"},{"key":"10.1002\/14651858.CD003614.pub3-BIB90|cit90","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","article-title":"Assessing the quality of reports of randomized clinical trials: is blinding necessary?","volume":"17","author":"Jadad","year":"1996","journal-title":"Controlled Clinical Trials"},{"issue":"5","key":"10.1002\/14651858.CD003614.pub3-BIB91|cit91","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1161\/01.RES.86.5.580","article-title":"The antianginal drug trimetazidine shifts cardiac energy metabolism from fatty acid oxidation to glucose oxidation by inhibiting mitochondrial long-chain 3-ketoacyl coenzyme A thiolase","volume":"86","author":"Kantor","year":"2000","journal-title":"Circulation Research"},{"key":"10.1002\/14651858.CD003614.pub3-BIB92|cit92","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1001\/archinte.1996.00440060089011","article-title":"The importance of quality of primary studies in producing unbiased systematic reviews","volume":"156","author":"Khan","year":"1996","journal-title":"Archives of Internal Medicine"},{"issue":"8","key":"10.1002\/14651858.CD003614.pub3-BIB93|cit93","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1097\/00019501-200212000-00008","article-title":"Efficacy of monotherapy compared with combined antianginal drugs in the treatment of chronic stable angina pectoris: a meta-analysis","volume":"13","author":"Klein","year":"2002","journal-title":"Coronary Artery Disease"},{"key":"10.1002\/14651858.CD003614.pub3-BIB94|cit94","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1093\/oxfordjournals.eurheartj.a060322","article-title":"Myocardial protection during percutaneous transluminal coronary angioplasty: effects of trimetazidine","volume":"13","author":"Kober","year":"1992","journal-title":"European Heart Journal"},{"key":"10.1002\/14651858.CD003614.pub3-BIB95|cit95","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1152\/jappl.1972.33.1.72","article-title":"Release of immunoreactive insulin from the human heart","volume":"33","author":"Lassers","year":"1972","journal-title":"Journal of Applied Physiology"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD003614.pub3-BIB96|cit96","doi-asserted-by":"crossref","first-page":"1S","DOI":"10.2165\/00003495-198900382-00003","article-title":"Profile of an ideal antianginal agent","volume":"38","author":"Lazar","year":"1989","journal-title":"Drugs"},{"issue":"3","key":"10.1002\/14651858.CD003614.pub3-BIB97|cit97","doi-asserted-by":"crossref","first-page":"E33","DOI":"10.1161\/01.RES.0000086964.07404.A5","article-title":"Beneficial effects of trimetazidine in ex vivo working ischemic hearts are due to a stimulation of glucose oxidation secondary to inhibition of long-chain 3-ketoacyl coenzyme A thiolase","volume":"93","author":"Lopaschuk","year":"2003","journal-title":"Circulation Research"},{"key":"10.1002\/14651858.CD003614.pub3-BIB98|cit98","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1136\/bmj.321.7253.62","article-title":"Treatment of stable angina","volume":"321","author":"L\u00fcscher","year":"2000","journal-title":"BMJ"},{"issue":"2","key":"10.1002\/14651858.CD003614.pub3-BIB99|cit99","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00019501-200304000-00010","article-title":"Efficacy and tolerability of trimetazidine in stable angina: a meta-analysis of randomized, double-blind, controlled trials","volume":"14","author":"Marzilli","year":"2003","journal-title":"Coronary Artery Disease"},{"issue":"1","key":"10.1002\/14651858.CD003614.pub3-BIB100|cit100","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2165\/00003495-199958010-00016","article-title":"Trimetazidine. A review of its use in stable angina pectoris and other coronary conditions","volume":"58","author":"McClellan","year":"1999","journal-title":"Drugs"},{"key":"10.1002\/14651858.CD003614.pub3-BIB101|cit101","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/S0306-3623(97)00301-7","article-title":"Ranolazine: a novel metabolic modulator for the treatment of angina","volume":"30","author":"McCormack","year":"1998","journal-title":"General Pharmacology"},{"key":"10.1002\/14651858.CD003614.pub3-BIB102|cit102","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1136\/bmj.309.6965.1343","article-title":"Recent advances in cardiology - 1: treatment of myocardial infarction, unstable angina, and angina pectoris","volume":"309","author":"McMurray","year":"1994","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD003614.pub3-BIB103|cit103","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1016\/S0140-6736(99)04149-5","article-title":"Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement","volume":"354","author":"Moher","year":"1999","journal-title":"Lancet"},{"issue":"6","key":"10.1002\/14651858.CD003614.pub3-BIB104|cit104","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/S0002-8703(03)00436-8","article-title":"Anginal symptoms consistently predict total mortality among outpatients with coronary artery disease","volume":"146","author":"Mozaffarian","year":"2003","journal-title":"American Heart Journal"},{"key":"10.1002\/14651858.CD003614.pub3-BIB105|cit105","unstructured":"North of England Evidence Based Guideline Development Project Evidence based clinical practice guidelines: The primary care management of stable angina Available at http:\/\/bmj.com\/collections\/angina\/ang01.shtml [Accessed 1\/7\/2005]"},{"key":"10.1002\/14651858.CD003614.pub3-BIB106|cit106","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0167-5273(96)02678-2","article-title":"The effect of Trimetazidine on reperfusion arrhytmias in acuta myocardial infarction","volume":"55","author":"Papadopoulos","year":"1996","journal-title":"International Journal of Cardiology"},{"key":"10.1002\/14651858.CD003614.pub3-BIB107|cit107","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/S0002-9149(98)00204-5","article-title":"Twenty-two-year follow-up in the VA cooperative study of coronary artery bypass surgery for stable angina","volume":"81","author":"Peduzzi","year":"1998","journal-title":"American Journal of Cardiology"},{"issue":"10","key":"10.1002\/14651858.CD003614.pub3-BIB108|cit108","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1002\/clc.4960231014","article-title":"Monotherapy with amlodipine or atenolol versus their combination in stable angina pectoris","volume":"23","author":"Pehrsson","year":"2000","journal-title":"Clinical Cardiology"},{"key":"10.1002\/14651858.CD003614.pub3-BIB109|cit109","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/0002-9149(94)90361-1","article-title":"Characteristics of a contemporary population with angina pectoris","volume":"74","author":"Pepine","year":"1994","journal-title":"American Journal of Cardiology"},{"issue":"4","key":"10.1002\/14651858.CD003614.pub3-BIB110|cit110","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/S0735-1097(99)00637-3","article-title":"Quality of life after coronary angioplasty or continued medical treatment for angina: three-year follow-up in the RITA-2 trial. Randomized Intervention Treatment of Angina","volume":"35","author":"Pocock","year":"2000","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1002\/14651858.CD003614.pub3-BIB111|cit111","unstructured":"Review Manager (RevMan) [Computer program]. Version 4.2 for Windows. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration 2003"},{"key":"10.1002\/14651858.CD003614.pub3-BIB112|cit112","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1136\/bmj.312.7026.265","article-title":"Chronic coronary artery disease: drugs, angiolasty or surgery?","volume":"312","author":"Rihal","year":"1996","journal-title":"BMJ"},{"issue":"9076","key":"10.1002\/14651858.CD003614.pub3-BIB113|cit113","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0140-6736(97)07298-X","article-title":"Coronary angioplasty versus medical therapy for angina: the second Randomised Intervention Treatment of Angina ( RITA-2)","volume":"350","author":"Chamberlain","year":"1997","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD003614.pub3-BIB114|cit114","first-page":"775","article-title":"Drugs used for the treatment of myocardial ischaemia","volume-title":"Goodman and Gilman's: The pharmacological basis of therapeutics","author":"Robertson","year":"1996"},{"issue":"5","key":"10.1002\/14651858.CD003614.pub3-BIB115|cit115","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1161\/01.CIR.82.5.1647","article-title":"Ten-year follow-up of quality of life in patients randomized to receive medical therapy or coronary artery bypass graft surgery. The Coronary Artery Surgery Study (CASS)","volume":"82","author":"Rogers","year":"1990","journal-title":"Circulation"},{"issue":"1","key":"10.1002\/14651858.CD003614.pub3-BIB116|cit116","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1475-2840-2-16","article-title":"Trimetazidine improves left ventricular function in diabetic patients with coronary artery disease: a double-blind placebo-controlled study","volume":"2","author":"Rosano","year":"2003","journal-title":"Cardiovascular Diabetology"},{"issue":"2","key":"10.1002\/14651858.CD003614.pub3-BIB117|cit117","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/0735-1097(95)00489-0","article-title":"Combination therapy with metoprolol and nifedipine versus monotherapy in patients with stable angina pectoris. Results of the international multicenter angina exercise (IMAGE) Study","volume":"27","author":"Savonitto","year":"1999","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1002\/14651858.CD003614.pub3-BIB118|cit118","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1001\/jama.1995.03520290060030","article-title":"Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials","volume":"273","author":"Schulz","year":"1995","journal-title":"JAMA"},{"issue":"10","key":"10.1002\/14651858.CD003614.pub3-BIB119|cit119","doi-asserted-by":"crossref","DOI":"10.3310\/hta2100","article-title":"Resource allocation for chronic stable angina: a systematic review of effectiveness, costs and cost-effectiveness of alternative interventions","volume":"2","author":"Sculpher","year":"1998","journal-title":"Health Technology Assessment"},{"issue":"5","key":"10.1002\/14651858.CD003614.pub3-BIB120|cit120","doi-asserted-by":"crossref","first-page":"361","DOI":"10.2165\/00129784-200303050-00007","article-title":"Assessment of anti-ischemic and antianginal effect at trough plasma concentration and safety of trimetazidine MR 35mg in patients with stable angina pectoris : A multicenter, double-blind, placebo-controlled study","volume":"3","author":"Sellier","year":"2003","journal-title":"American Journal of Cardiovascular Drugs"},{"issue":"Abstract Suppl","key":"10.1002\/14651858.CD003614.pub3-BIB121|cit121","first-page":"365","article-title":"A randomized, double-blind trial of trimetazidine as adjuntive therapy to primary PTCA for acute myocardial infarction: evidence for improved myocardial reperfusion from ST-segmente analysis [abstract]","volume":"19","author":"Steg","year":"1998","journal-title":"Eurpean Heart Journal"},{"key":"10.1002\/14651858.CD003614.pub3-BIB122|cit122","doi-asserted-by":"crossref","DOI":"10.1002\/9780470693926.ch18","article-title":"Meta-analysis in Stata","volume-title":"Systematic Reviews in Health Care","author":"Sterne","year":"2001"},{"key":"10.1002\/14651858.CD003614.pub3-BIB123|cit123","series-title":"Congreso de la Sociedad Europea de Cardiolog\u00eda (abstract)","article-title":"Efficacy and safety of trimetazidine in patients with persistent stable angina pectoris under beta-blocker therapy: TRIMPOL-II multicenter study Congreso de la Sociedad Europea de Cardiolog\u00eda","author":"Szwed","year":"1999"},{"issue":"1","key":"10.1002\/14651858.CD003614.pub3-BIB124|cit124","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00044011-200019010-00001","article-title":"Anti-ischaemic efficacy and tolerability of trimetazidine in elderly patients with angina pectoris. A sub-study from TRIMPOL-1 (Trimetazidine in Poland)","volume":"19","author":"Szwed","year":"2000","journal-title":"Clinical Drug Investigation"},{"issue":"4","key":"10.1002\/14651858.CD003614.pub3-BIB125|cit125","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1097\/00001573-199907000-00011","article-title":"Treatment of stable angina","volume":"14","author":"Thadani","year":"1999","journal-title":"Current Opinion in Cardiology"},{"key":"10.1002\/14651858.CD003614.pub3-BIB126|cit126","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1177\/096228029300200205","article-title":"Controversies in meta-analysis: the case of the trials of serum cholesterol reduction","volume":"2","author":"Thompson","year":"1993","journal-title":"Statistical Methods in Medical Research"},{"key":"10.1002\/14651858.CD003614.pub3-BIB127|cit127","first-page":"712","article-title":"Myocardial protection during coronary artery bypass graft surgry: a randomized, double-blind, placebo-controlled study with trimetazidine","volume":"82","author":"Vedrinne","year":"1996","journal-title":"Anesthesia & Analgesia"},{"key":"10.1002\/14651858.CD003614.pub3-BIB128|cit128","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1001\/archinte.158.17.1901","article-title":"National patterns and predictors of beta-blocker use in patients with coronary artery disease in patients with coronary artery disease","volume":"158","author":"Wang","year":"1998","journal-title":"Archives of Internal Medicine"},{"key":"10.1002\/14651858.CD003614.pub3-BIB129|cit129","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0033-0620(85)80003-7","article-title":"Beta blockade during and after myocardial infarction","volume":"27","author":"Yusuf","year":"1985","journal-title":"Progress in Cardiovascular Diseases"},{"key":"10.1002\/14651858.CD003614.pub3-BIB130|cit130","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/S0140-6736(94)91963-1","article-title":"Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration","volume":"344","author":"Yusuf","year":"1994","journal-title":"Lancet"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD003614.pub3\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,28]],"date-time":"2023-11-28T02:16:54Z","timestamp":1701137814000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD003614.pub3"}},"subtitle":[],"editor":[{"name":"Cochrane Heart Group","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2017,3,20]]},"references-count":130,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2017,3]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd003614.pub3","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,20]]}}}